Effect of a polysaccharide‐rich hydrolysate from Saccharomyces cerevisiae (LipiGo®) in body weight loss: randomised, double‐blind, placebo‐controlled clinical trial in overweight and obese adults
Authors:
- 21 April 2017
- journal article
- research article
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 97 (12) , 4250-4257
Abstract
BACKGROUND: In the present study we evaluated the weight loss effect of a polysaccharide‐rich food supplement, LipiGo®, comprising a specific β‐glucan–chitin–chitosan fraction (BGCC) obtained from the chemical hydrolysis of Saccharomyces cerevisiae, resulting as a by‐product of the brewing process.RESULTS: A randomised, double‐blind, placebo‐controlled clinical trial was performed enrolling 56 overweight and obese subjects (body mass index, BMI, 25–35 kg m−2) who were not following any specific diet, and were given placebo or BGCC (3 g d−1) for 12 weeks. Results were analysed by intention‐to‐treat (ITT) and per‐protocol (PP) methods. Body weight increased in the placebo group compared to baseline (ITT: 1.0 kg, P < 0.001; PP: 1.5 kg, P = 0.003), while it was slightly lowered in the BGCC group (ITT: −0.8 kg, P = 0.210; PP: −1.1 kg, P = 0.182). BGCC, but not the consumption of placebo, also resulted in a reduction of waist circumference and body fat compared to baseline.CONCLUSIONS: Results suggest that daily supplementation of BGCC may be useful for improving body weight and waist circumference in overweight and obese subjects, without relevant adverse effects. © 2017 Society of Chemical IndustryKeywords
This publication has 23 references indexed in Scilit:
- Beta Glucan: Health Benefits in Obesity and Metabolic SyndromeJournal of Nutrition and Metabolism, 2011
- Nutraceutical Supplements for Weight LossNutrition in Clinical Practice, 2011
- Symptoms Associated With Dietary Fiber Supplementation Over Time in Individuals With Fecal IncontinenceNursing Research, 2011
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharidesFood & Function, 2010
- Effects of yeast-derived β-glucans on blood cholesterol and macrophage functionalityJournal of Immunotoxicology, 2009
- WHO recognition of the global obesity epidemicInternational Journal of Obesity, 2008
- Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trialNutrition Journal, 2007
- A new non-degrading isolation process for 1,3-β-d-glucan of high purity from baker's yeast Saccharomyces cerevisiaeCarbohydrate Polymers, 2003
- The Yeast Cell Wall and Septum as Paradigms of Cell Growth and MorphogenesisJournal of Biological Chemistry, 2001